EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C
Clinical trial NCT02097966 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02097966
- Sponsor
- Bristol-Myers Squibb
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.